PELLEGRINO, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 758
EU - Europa 543
AS - Asia 327
SA - Sud America 57
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.707
Nazione #
US - Stati Uniti d'America 746
IE - Irlanda 185
SG - Singapore 155
CN - Cina 146
IT - Italia 118
SE - Svezia 118
BR - Brasile 52
DE - Germania 40
AT - Austria 23
CI - Costa d'Avorio 12
FI - Finlandia 12
BE - Belgio 10
CA - Canada 10
GB - Regno Unito 8
CZ - Repubblica Ceca 7
IN - India 5
TR - Turchia 5
FR - Francia 4
NL - Olanda 4
AL - Albania 3
ES - Italia 3
LT - Lituania 3
PL - Polonia 3
ZA - Sudafrica 3
A1 - Anonimo 2
BD - Bangladesh 2
EC - Ecuador 2
HK - Hong Kong 2
MA - Marocco 2
SA - Arabia Saudita 2
VE - Venezuela 2
AZ - Azerbaigian 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 1.707
Città #
Dublin 185
Chandler 179
Singapore 127
Santa Clara 108
Shanghai 55
Boardman 54
Ashburn 51
New York 49
Beijing 35
Ann Arbor 23
Princeton 22
Bremen 21
Vienna 21
Seattle 18
Dearborn 13
Des Moines 13
Parma 13
Abidjan 12
Helsinki 12
Milan 10
Ardea 8
Brussels 8
Wilmington 8
Los Angeles 7
Ravenna 7
São Paulo 7
Bologna 5
Falls Church 5
Nuremberg 5
Olomouc 5
Rio Saliceto 5
Toronto 5
Cascina 4
Council Bluffs 4
Nanjing 4
Pavia 4
Reggio Emilia 4
Rome 4
Fairfield 3
Hangzhou 3
Kunming 3
Montreal 3
Nanchang 3
Shenzhen 3
Tirana 3
Verona 3
Woodbridge 3
Bastia umbra 2
Brooklyn 2
Campinas 2
Capriate San Gervasio 2
Frankfurt am Main 2
Hebei 2
Izmir 2
Jinan 2
London 2
Madrid 2
Marseille 2
Menlo Park 2
Munich 2
Newark 2
Osasco 2
Rio de Janeiro 2
Riyadh 2
Scarperia e San Piero 2
Stockholm 2
São Bernardo do Campo 2
Trento 2
Almaty 1
Amsterdam 1
Anajatuba 1
Andover 1
Ardabil 1
Auckland 1
Augusta 1
Baku 1
Bauru 1
Bonito 1
Borås 1
Brno 1
Brumado 1
Buíque 1
Cabo de Santo Agostinho 1
Campina Grande 1
Campos dos Goytacazes 1
Canoinhas 1
Caracas 1
Carangola 1
Carazinho 1
Casablanca 1
Chongqing 1
Ciudad Ojeda 1
Cochabamba 1
Colombo 1
Concórdia 1
Corno di Rosazzo 1
Curitiba 1
Divinópolis 1
Doha 1
Dourados 1
Totale 1.221
Nome #
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression 86
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 84
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature 83
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 76
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 70
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 69
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 67
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 67
Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient 65
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 65
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 62
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 58
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 58
A review of immune checkpoint blockade in breast cancer 58
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 58
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review 55
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 52
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review 51
My best choice after a round trip from illness 50
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 49
A narrative review of the principal glucocorticoids employed in cancer 49
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 48
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification 46
PARP inhibition increases immune infiltration in homologous recombination repair (HRR)-deficient tumors 45
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 39
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review 37
The Innate Immune Microenvironment in Metastatic Breast Cancer 35
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 34
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 24
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 23
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 22
Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients 20
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 20
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors 20
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 18
Totale 1.763
Categoria #
all - tutte 9.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 0 0 0 2 2 40 10 1
2020/202189 2 8 1 5 6 14 15 12 4 6 13 3
2021/202296 1 2 6 7 5 6 7 5 2 8 0 47
2022/2023652 49 66 33 48 70 71 4 47 214 4 38 8
2023/2024335 13 29 6 4 26 74 34 41 13 28 29 38
2024/2025488 36 40 59 52 113 98 53 37 0 0 0 0
Totale 1.763